Although PSMA is expressed on the endothelium of these tumors, allowing for theoretical targeting and treatment with LuPSMA, this endothelial expression results in minimal retention of PSMA-targeted molecules within the tumor. The gene discussed is FOLH1; the disease is neoplasm.